Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 2,210.00
+15.00 (0.68%)
At close: Sep 9, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 207.86 billion as of September 9, 2026. Its market cap has increased by 62.26% in one year.
Market Cap
207.86B
Enterprise Value
189.63B
Revenue
3.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,210.00
ChartMarket Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 207.86B, an increase of 60.72%. That is a compound annual growth rate of 4.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 207.86B | -4.74% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 302.34B |
| S.Biomedics | 271.23B |
| IntoCell | 263.18B |
| IMBiologics | 227.98B |
| curacle co.,ltd. | 207.71B |
| Kanaph Therapeutics | 181.69B |
| Genome & Company | 171.80B |
| NIBEC | 168.13B |